Retatrutide 60mg*10vials

描述

Core Features
Ultra-High Purity (≥99.0%) & High-Capacity Conformational Fidelity:
This product is manufactured using industry-leading automated high-throughput solid-phase peptide synthesis (SPPS) technology. Given Retatrutide’s complex heterogeneous peptide chain structure and the exceptionally high 60mg fill weight per vial, the synthesis process—particularly intermediate control and final purification—presents significant technical challenges. We employ precise industrial-grade reversed-phase preparative HPLC (RP-HPLC) to rigorously eliminate by-products such as racemates, truncated sequences, and mis-sequences. Each 60mg vial guarantees a baseline purity of ≥99.0%, providing a clean, interference-free matrix for large-scale in vitro receptor affinity assays and long-term in vivo animal metabolic studies.
Synergistic Triple-Agonist Mechanism:
Retatrutide is a standout molecule in metabolic research, capable of binding with high affinity to three key metabolic receptors: GIPR (glucose-dependent insulinotropic polypeptide receptor), GLP-1R (glucagon-like peptide-1 receptor), and GCGR (glucagon receptor). Its unique triple-agonist structure makes it an indispensable tool for investigating mechanisms involving multi-receptor synergy—specifically the suppression of appetite, delayed gastric emptying, the browning of white adipose tissue, and the upregulation of overall energy expenditure.
Advanced Cryo-Lyophilization Process:
The high-concentration (60mg) peptide powder undergoes moisture sublimation at ultra-low temperatures (-80°C) and near-absolute vacuum conditions, resulting in a uniform, robust, and collapse-free crystalline “lyophilized cake” structure. This process not only ensures excellent reconstitution properties—allowing for dissolution within seconds—using sterile water for injection or normal saline, resulting in a clear, bubble-free solution—but also stabilizes the molecule’s secondary structure. This significantly mitigates the risks of thermal degradation and conformational loss during international transit and prolonged customs clearance.

🛠️ Technical Specifications & Parameters
Parameter Specification Details
Product Specification 60 mg / Vacuum-Sealed Glass Vial
Molecular Formula C211 H342 N54 O68
Appearance White to off-white sterile lyophilized powder / intact solid cake
Validation Supplied with original manufacturer HPLC purity chromatograms and MS molecular weight verification reports (one certificate per vial; supports digital traceability and batch verification against manufacturer records).

❄️ Storage Requirements & Comprehensive Cold Chain Protection
Laboratory Storage Protocol: Upon receipt, the product must be stored immediately in an explosion-proof, research-grade ultra-low temperature freezer (–20°C to –80°C) while in its unreconstituted state. Maintain conditions that ensure protection from light and moisture, alongside a high-vacuum seal. Storage in standard household appliances or office equipment lacking temperature logging capabilities is strictly prohibited. Given the large 60 mg fill volume and the product’s susceptibility to degradation post-reconstitution, researchers are strongly advised to aliquot the sample based on single-dose animal administration requirements and freeze the portions; repeated freeze-thaw cycles are strictly prohibited.
Pharmaceutical-Grade Cold Chain Shipping: Strictly adheres to the platform’s “International Shipping and Order Scheduling” policies. For the 60mg Retatrutide, we utilize high-density, thickened five-layer insulated foam boxes as the standard packaging. Shipments are expedited using high-capacity, phase-change gel packs to ensure that the peptide molecules maintain their complex spatial conformation in a stable, “locked-in” cold state while traversing diverse global climate zones.

📝 Scientific Compliance & Disclaimer (Research Limitations & Compliance)
⚠️ Strictly for Laboratory Research Use Only (RUO):
This product (Retatrutide 60mg) is a chemical reagent intended for cutting-edge life science research. In strict adherence to global biosafety and compliance standards, this product is restricted to academic research within university laboratories, research institutes, or R&D centers of biopharmaceutical companies (e.g., experiments on cell receptor binding affinity, long-term metabolic cohort monitoring in large animal models, etc.). Any unauthorized use—including human clinical injection, oral administration, substitution for medical prescriptions, or use as an illicit weight-loss agent or performance-enhancing drug/stimulant in sports—is strictly prohibited. This platform enforces a rigorous multi-stage review process based on the “End-Use Statement”; any orders suspected of misuse will be unconditionally cancelled and reported to the relevant compliance authorities.